Major Adverse Cardiac Events After Carotid Endarterectomy
NCT ID: NCT03596229
Last Updated: 2020-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
175 participants
OBSERVATIONAL
2018-10-01
2020-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparison of Cognitive Function After Carotid Endarterectomy and Stenting
NCT02220595
Early Warning and Optimization Strategy in Carotid Endarterectomy
NCT01210937
Change of Hemodynamics and Cerebral Functions After Carotid Artery Revascularization
NCT05539781
Efficacy and Outcome of Carotid Endarterectomy for Symptomatic Carotid Stenosis
NCT06756360
Risk Prediction of Carotid Endarterectomy by Vascular Ultrasound Evaluation
NCT03785626
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Myocardial infarction is defined as rising of cardiac bio-markers in the setting of myocardial ischemia (Relevant anginal symptoms, ECG changes or Imaging e.g. Echocardiography)2,10
* Significant arrhythmia is defined as symptomatic or causing hemodynamic changes without other explainable causes.
* Heart failure is defined according to Modified Framingham criteria3
* Cardiac death is defined as mortality in association and as a direct result from myocardial infarction, arrhythmia or heart failure
if possible, the investigators will try to find the associate or risk factors for those events.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aphichat Suphathamwit,
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aphichat Suphathamwit, M.D.
Role: PRINCIPAL_INVESTIGATOR
Mahidol University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine Siriraj Hospital
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
1. Mutirangura P et al. J Med Assoc Thai 2016; 99 (7): 785-93. 2. Boulanger M et al. Stroke. 2015 Oct;46(10):2843-8. 3. McKee PA et al. N Engl J Med. 1971 Dec 23;285(26):1441-6. 4.Go C et al. Ann Vasc Surg. 2015 Aug;29(6):1265-71. 5.Steinvil A et al. J Am Coll Cardiol. 2011 Feb 15;57(7):779-83. 6.Hoffmann R et al. Heart. 2005 Nov;91(11):1438-41. 7.Sposato LA et al. Journal of the Neurological Sciences. 2011 Oct 15;309(1-2):5-8. 8.Aboyans V et al. Eur Heart J. 2018 Mar 1;39(9):763-816. 9.Varon J, Marik PE. Vasc Health Risk Manag. 2008 Jun; 4(3): 615-627. 10.Landesberg G et al. Circulation. 2009;119:2936-2944
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.